Abnormal involuntary movement scale in tardive dyskinesia: Minimal clinically important difference

BACKGROUND: A minimal clinically important difference has not been established for the Abnormal Involuntary Movement Scale in patients with tardive dyskinesia. Valbenazine is a vesicular monoamine transporter 2 inhibitor approved for the treatment of tardive dyskinesia in adults. Efficacy in randomi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mov Disord
Main Authors: Stacy, Mark, Sajatovic, Martha, Kane, John M., Cutler, Andrew J., Liang, Grace S., O'Brien, Christopher F., Correll, Christoph U.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2019
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6772010/
https://ncbi.nlm.nih.gov/pubmed/31234240
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.27769
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados